Advances in Clinical and Experimental Medicine
2019, vol. 28, nr 5, May, p. 581–585
Publication type: original article
Influence of temperature rise by 2.5°C on the increase of apoptosis of HL-60 cells treated with busulfan
1 Faculty of Electrical Engineering, Wrocław University of Science and Technology, Poland
2 Department and Clinic of Hematology, Blood Neoplasms and Bone Marrow Transplantations, Wroclaw Medical University, Poland
Background. Hyperthermia is one of the new and still poorly known methods used in cancer treatment. It consists of raising the patient’s body temperature for therapeutic purposes. The article presents the results of in vitro studies describing the effect of an elevated temperature of 39.5°C, the busulfan cytostatic and their combination on the level of apoptosis of human leukemia HL-60 cells.
Objectives. During the experiments, the influence of a 2.5°C temperature increase on the behavior of the population of 2 groups of HL-60 cells, with busulfan cytostatic and without the cytostatic, was investigated. The control group consisted of 2 groups of HL-60 cells incubated at 37.0°C with the cytostatic and without the cytostatic. Two questions were asked: 1. Is low-temperature hyperthermia likely to have an effect on the effectiveness of busulfan cytostatic? 2. Does the increase in temperature by 2.5°C have an effect on the level of apoptosis in the unsaturated HL-60 cell line?
Material and Methods. Human promyelocytic leukemia cell line HL-60 was used in the experiments to examine the influence of temperature on apoptosis HL-60 in 2 separated incubators set to 37.0°C and 39.5°C for 3 h. Apoptosis was assessed with flow cytometry using Annexin V.
Results. An increase in mortality of HL-60 cells was found in the case of simultaneous exposure to elevated temperature and busulfan in comparison to the group of cells treated with the cytostatic alone. There was no observed effect of an elevated temperature of 39.5°C alone on the level of HL-60 cell apoptosis.
Conclusion. Analysis of the study results indicates that low-temperature hyperthermia may be used to increase the effectiveness of busulfan treatment. No effect of an elevated temperature of 39.5°C on the level of apoptosis in HL-60 cells that were not treated with busulfan was observed. There is a need to test the efficacy of other cytostatic agents at elevated temperatures.
apoptosis, in vitro, hyperthermia, busulfan, HL-60 cell line
- Beik J, Abed Z, Ghoreishi FS, et al. Nanotechnology in hyperthermia cancer therapy: From fundamental principles to advanced applications. J Control Release. 2016;23(5):205–221.
- Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002;3(8):487–497.
- Ahmed M, Goldberg SN. Basic science research in thermal ablation. Surg Oncol Clin N Am. 2011;20(2):237–258.
- Kluger MJ, Ringler DH, Anver MR. Fever and survival. Science. 1975;188(4184):166–168.
- Hobohm U. Fever and cancer in perspective. Cancer Immunol Immunother. 2001;50(8):391–396.
- Kobayashi Y, Ito Y, Ostapenko VV, et al. Fever-range whole-body heat treatment stimulates antigen-specific T-cell responses in humans. Immunol Lett. 2014;162(1 Pt A):256–261.
- Rowe RW, Strebel FR, Proett JM, et al. Fever-range whole-body thermotherapy combined with oxaliplatin: A curative regimen in a preclinical breast cancer model. Int J Hyperthermia. 2010;26(6):565–576.
- Baronzio G, Seta R, D'Amico M, et al. Effects of local and whole body hyperthermia on immunity. https://www.ncbi.nlm.nih.gov/books/NBK6083/. Accessed January 18, 2019.
- Tang JC, Shi HS, Wan LQ, Wang YS, Wei YQ. Enhanced antitumor effect of curcumin liposomes with local hyperthermia in the LL/2 model. Asian Pac J Cancer Prev. 2013;14(4):2307–2310.
- Yan X, Xiu F, An H, Wang X, Wang J, Cao X. Fever range temperature promotes TLR4 expression and signaling in dendritic cells. Life Sci. 2007;80(4):307–313.
- Van der Zee J. Heating the patient: A promising approach? Ann Oncol. 2002;13(8):1173–1184.